Virtu Financial’s China SXT Pharmaceuticals SXTC Stock Holding History

Virtu Financial’s Portfolio SXTC Stock Details SXTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1	Closed	-$20K	–	2284
2025 Q4	$20K	Sell	1 -1	-50%	-$17.3K	﹤0.01%	1429
2025 Q3	$46K	Buy	2 +1	+100%	+$19.8K	﹤0.01%	1147
2025 Q2	$24K	Buy	+1	New	+$22.7K	﹤0.01%	1238
2024 Q3	–	Hold	0	–	-$34K	–	1867
2024 Q2	–	Hold	0	–	–	–	959
2023 Q2	–	Hold	0	–	-$11K	–	2018
2023 Q1	–	Hold	0	–	–	–	1339
2022 Q4	–	Hold	0	–	–	–	1093
2022 Q3	–	Hold	0	–	-$26K	–	2224
2022 Q2	–	Hold	0	–	–	–	1279
2022 Q1	–	Hold	0	–	–	–	1265
2021 Q4	–	Hold	0	–	–	–	1463
2021 Q3	–	Hold	0	–	–	–	1307
2020 Q4	–	Hold	0	–	-$5K	–	1778
2020 Q3	–	Hold	0	–	–	–	970
2019 Q2	–	Hold	0	–	-$182K	–	1852
2019 Q1	–	Hold	0	–	–	–	1027

Other funds holding SXTC

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Virtu Financial's SXTC Position: Q1 2026 in Review

Virtu Financial sold out of China SXT Pharmaceuticals (SXTC) in Q1 2026, closing a stake of 1 share — an estimated $20K sold.

Virtu Financial first reported a position in SXTC in Q2 2025 and held it in 3 quarters. The position peaked at $46K in Q3 2025. 1 fund tracked by Wall St. Rank holds SXTC as of Q1 2026.

Virtu Financial reported no remaining China SXT Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Virtu Financial sold 1 China SXT Pharmaceuticals share in Q1 2026, an estimated $20K.
Virtu Financial first reported a position in China SXT Pharmaceuticals in Q2 2025 and held it in 3 quarters.
Virtu Financial's China SXT Pharmaceuticals position peaked at $46K in Q3 2025.
1 fund tracked by Wall St. Rank held China SXT Pharmaceuticals as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.